BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu ZW, Lu HF, Wu J, Zuo J, Chen P, Sheng JF, Zheng SS, Li LJ. Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant. Microb Ecol. 2012;63:929-937. [PMID: 21965156 DOI: 10.1007/s00248-011-9945-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Li YG, Yu ZJ, Li A, Ren ZG. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions. World J Gastroenterol 2022; 28(28): 3555-3572 [DOI: 10.3748/wjg.v28.i28.3555] [Reference Citation Analysis]
2 Chen B, Huang H, Pan CQ. The role of gut microbiota in hepatitis B disease progression and treatment. J Viral Hepat 2021. [PMID: 34415656 DOI: 10.1111/jvh.13595] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Nishimura N, Kaji K, Kitagawa K, Sawada Y, Furukawa M, Ozutsumi T, Fujinaga Y, Tsuji Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Fukui H, Yoshiji H. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. Int J Mol Sci 2021;22:6921. [PMID: 34203178 DOI: 10.3390/ijms22136921] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Jiang XW, Li YT, Ye JZ, Lv LX, Yang LY, Bian XY, Wu WR, Wu JJ, Shi D, Wang Q, Fang DQ, Wang KC, Wang QQ, Lu YM, Xie JJ, Li LJ. New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism. World J Gastroenterol 2020; 26(40): 6224-6240 [PMID: 33177795 DOI: 10.3748/wjg.v26.i40.6224] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
5 Sadiq FA. Is it time for microbiome-based therapies in viral infections? Virus Res 2021;291:198203. [PMID: 33132161 DOI: 10.1016/j.virusres.2020.198203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Jomehzadeh N, Javaherizadeh H, Amin M, Rashno M, Teimoori A. Quantification of Intestinal Lactobacillus Species in Children with Functional Constipation by Quantitative Real-Time PCR. Clin Exp Gastroenterol 2020;13:141-50. [PMID: 32440191 DOI: 10.2147/CEG.S250755] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen Z, Xie Y, Zhou F, Zhang B, Wu J, Yang L, Xu S, Stedtfeld R, Chen Q, Liu J, Zhang X, Xu H, Ren J. Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease. Front Microbiol 2020;11:383. [PMID: 32265857 DOI: 10.3389/fmicb.2020.00383] [Cited by in Crossref: 11] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
8 Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Am J Physiol Gastrointest Liver Physiol 2020;318:G889-906. [PMID: 32146836 DOI: 10.1152/ajpgi.00161.2019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
9 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 45] [Article Influence: 10.3] [Reference Citation Analysis]
10 Iacob S, Iacob DG. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Front Microbiol 2019;10:1676. [PMID: 31447793 DOI: 10.3389/fmicb.2019.01676] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
11 Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 2019;76:1541-58. [PMID: 30683985 DOI: 10.1007/s00018-019-03011-w] [Cited by in Crossref: 101] [Cited by in F6Publishing: 155] [Article Influence: 33.7] [Reference Citation Analysis]
12 Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H. Management of refractory cirrhotic ascites: challenges and solutions. Hepat Med. 2018;10:55-71. [PMID: 30013405 DOI: 10.2147/hmer.s136578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mohamadkhani A. On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B. Cancer Med. 2018;. [PMID: 29761927 DOI: 10.1002/cam4.1550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang J, Ma J, Wang H, Li J. Correlation between cortisol levels and concurrent infection for hepatitis B cirrhosis patients and countermeasure analysis. Exp Ther Med 2018;15:2951-5. [PMID: 29456701 DOI: 10.3892/etm.2018.5738] [Reference Citation Analysis]
15 Tian X, Yang Z, Luo F, Zheng S. Gut microbial balance and liver transplantation: alteration, management, and prediction. Front Med 2018;12:123-9. [PMID: 29230676 DOI: 10.1007/s11684-017-0563-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Fukui H. Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step. J Clin Transl Hepatol 2017;5:249-60. [PMID: 28936406 DOI: 10.14218/JCTH.2017.00008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect 2017;96:342-8. [PMID: 28545829 DOI: 10.1016/j.jhin.2017.04.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
18 Althani AA, Marei HE, Hamdi WS, Nasrallah GK, El Zowalaty ME, Al Khodor S, Al-Asmakh M, Abdel-Aziz H, Cenciarelli C. Human Microbiome and its Association With Health and Diseases. J Cell Physiol 2016;231:1688-94. [PMID: 26660761 DOI: 10.1002/jcp.25284] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 10.2] [Reference Citation Analysis]
19 Carotti S, Guarino MPL, Vespasiani-Gentilucci U, Morini S. Starring role of toll-like receptor-4 activation in the gut-liver axis. World J Gastrointest Pathophysiol 2015; 6(4): 99-109 [PMID: 26600967 DOI: 10.4291/wjgp.v6.i4.99] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
20 Fukui H. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms. 2015;3:759-791. [PMID: 27682116 DOI: 10.3390/microorganisms3040759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
21 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med. 2015;13:275. [PMID: 26298517 DOI: 10.1186/s12967-015-0640-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
22 Li Y, Han T. Mechanisms of susceptibility to bacterial infections in cirrhotic patients. Shijie Huaren Xiaohua Zazhi 2015; 23(22): 3560-3566 [DOI: 10.11569/wcjd.v23.i22.3560] [Reference Citation Analysis]
23 van Best N, Jansen PL, Rensen SS. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. Hepatol Int. 2015;9:406-415. [PMID: 26067771 DOI: 10.1007/s12072-015-9640-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
24 Tilg H, Gao B. Dietary saturated lipids in alcoholic liver disease: new microbiota-targeting bullets? Gastroenterology 2015;148:16-9. [PMID: 25451649 DOI: 10.1053/j.gastro.2014.11.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, van Pijkeren JP, DePew J, Loomba R, Ho SB. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015;148:203-214.e16. [PMID: 25239591 DOI: 10.1053/j.gastro.2014.09.014] [Cited by in Crossref: 154] [Cited by in F6Publishing: 180] [Article Influence: 19.3] [Reference Citation Analysis]
26 Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513-1524. [PMID: 24440671 DOI: 10.1053/j.gastro.2014.01.020] [Cited by in Crossref: 487] [Cited by in F6Publishing: 529] [Article Influence: 60.9] [Reference Citation Analysis]
27 Lin SH, Ding H, Mao F, Xue LY, Lv WW, Zhu HG, Huang BJ, Wang WP. Non-invasive assessment of liver fibrosis in a rat model: shear wave elasticity imaging versus real-time elastography. Ultrasound Med Biol 2013;39:1215-22. [PMID: 23602805 DOI: 10.1016/j.ultrasmedbio.2013.02.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
28 Hartmann P, Chen WC, Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol 2012;3:402. [PMID: 23087650 DOI: 10.3389/fphys.2012.00402] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]